Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

An Indirect Comparison of Elranatamab's Progression-Free Survival and Overall Survival from Magnetismm-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

Luciano Costa, Thomas W LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco DiBonaventura

Blood (2023) 142 (Supplement 1): 6716.

https://doi.org/10.1182/blood-2023-180848

Published: 2023

Journal Articles

A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study

B. Douglas Smith, Curtis A Lachowiez, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Assaf Vestin, Robert Paglia, Ravi Potluri, Eros Papademetriou, Thomas W LeBlanc

Blood (2023) 142 (Supplement 1): 971.

https://doi.org/10.1182/blood-2023-173033

Published: 2023

Journal Articles

Multi-Site Randomized Trial of Inpatient Palliative Care for Hospitalized Patients Undergoing Hematopoietic Stem Cell Transplantation

Areej El-Jawahri, Thomas W LeBlanc, Alison Kavanaugh, Jason Webb, James Fausto, Lara Traeger, Joseph Greer, Vicki Jackson, Nora Horick, Zachariah Defilipp, Yi-Bin Chen, Stephanie J. Lee, Jennifer Temel

Blood (2023) 142 (Supplement 1): 913.

https://doi.org/10.1182/blood-2023-185735

Published: 2023

Journal Articles

A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH) to Promote Well-Being: Randomized Controlled Feasibility and Preliminary Efficacy Trial

Hermioni L Amonoo, Michelle Guo, Elizabeth Daskalakis, Emma Deary, Stephanie J. Lee, Thomas W LeBlanc, Jeff C. Huffman, Areej El-Jawahri

Blood (2023) 142 (Supplement 1): 2203.

https://doi.org/10.1182/blood-2023-179944

Published: 2023

Journal Articles

Comparative Analysis of Clinical Outcomes and Healthcare Resource Utilization (HRU) in Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Unfit for High-Intensity Chemotherapy Treated with Venetoclax (VEN) Vs Other Therapies: Results from the AML Real World Evidence (ARC) Initiative

Blood (2023) 142 (Supplement 1): 5173.

https://doi.org/10.1182/blood-2023-173283

Published: 2023

Journal Articles

Changing Care Journey for Patients with Multiple Myeloma in the United States

Darcy R Flora, Rachel Byrd, Daniel Platt, Patrick Hlavacek, Erinn Hoag Goldman, Joseph C Cappelleri, C Todd Kennedy, Thomas W LeBlanc

Blood (2023) 142 (Supplement 1): 7383.

https://doi.org/10.1182/blood-2023-179554

Published: 2023

Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Isha Mol, Yannan Hu, Thomas W LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek

Blood (2023) 142 (Supplement 1): 6731.

https://doi.org/10.1182/blood-2023-185920

Published: 2023

Journal Articles

Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation

Richard Newcomb, Hermioni L Amonoo, Ashley M Nelson, Joanna Choe, Katherine Holmbeck, Anisa Nably, Stephanie J. Lee, Thomas W LeBlanc, Areej El-Jawahri

Blood (2023) 142 (Supplement 1): 2424.

https://doi.org/10.1182/blood-2023-179471

Published: 2023

Journal Articles

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Pamela Egan, Ari Pelcovits, Caitlyn Krar, Stephen Donnelly, Lila Rubin, Rabin Niroula, John L. Reagan, Dana Guyer, Adam J Olszewski, Thomas W LeBlanc

Blood (2023) 142 (Supplement 1): 259.

https://doi.org/10.1182/blood-2023-187645

Published: 2023

Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab and Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Isha Mol, Yannan Hu, Thomas W LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek

Blood (2023) 142 (Supplement 1): 2015.

https://doi.org/10.1182/blood-2023-186409

Published: 2023

Journal Articles

Multiple Myeloma Treatment-Related Decision-Making and Preferences of Patients and Care Partners in the United States

Darcy R Flora, Rachel Byrd, Daniel Platt, Patrick Hlavacek, Erinn Hoag Goldman, Joseph C Cappelleri, C Todd Kennedy, Thomas W LeBlanc

Blood (2023) 142 (Supplement 1): 7357.

https://doi.org/10.1182/blood-2023-180951

Published: 2023

Journal Articles

Measuring Social Toxicity in Acute Myeloid Leukemia

Erica E Fortune, Kimberly Rogers, Caroline Lawrence, Claire Saxton, Victoria G Morris, Thomas W LeBlanc, Maria Sae-Hau, Melissa F Miller

Blood (2023) 142 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2023-177783

Published: 2023

Journal Articles

The Role of a Multi-Center Tumor Board Discussion in Managing Acute Leukemia in Under-Resourced Settings

Christopher Mwaniki Wanjiku, Thomas W. LeBlanc, Carole Kilach, Kenneth Cornetta, Beatrice Melly, Lindsay Dow, Austin Okuku, Kirstin Binz, Teresa Cherop Lotodo, Nelson J. Chao

Blood (2022) 140 (Supplement 1): 8138–8139.

https://doi.org/10.1182/blood-2022-170940

Published: 2022

Journal Articles

The Mental Health Burden and Quality of Life Impact of Myelodysplastic Syndromes in Patients and Their Caregivers

Katherine W DiNardo, Alice Houk, Christine Shim, Kristen Backor, Erika Sloan, Jolien Sweere, Isabel N Schuermeyer, Mary K Hughes, Thomas W. Leblanc

Blood (2022) 140 (Supplement 1): 8122–8123.

https://doi.org/10.1182/blood-2022-155893

Published: 2022

Journal Articles

In Their Own Words: A Qualitative Study of Coping Mechanisms Employed By Patients with Acute Myeloid Leukemia

Nikki Daniels, Monica Bodd, Susan C. Locke, Thomas W. Leblanc

Blood (2022) 140 (Supplement 1): 13267–13268.

https://doi.org/10.1182/blood-2022-165372

Published: 2022

Journal Articles

The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World

Blood (2022) 140 (Supplement 1): 13264–13266.

https://doi.org/10.1182/blood-2022-159637

Published: 2022

Journal Articles

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Pamela C Egan, Aryeh Pelcovits, Thomas W. Leblanc, Caitlyn Krar, Stephen Donnelly, Lila Rubin, Adam Olszewski, John L Reagan, Rabin Niroula

Blood (2022) 140 (Supplement 1): 7946–7947.

https://doi.org/10.1182/blood-2022-156951

Published: 2022

Journal Articles

Code Status Transitions in Patients with High-Risk Acute Myeloid Leukemia (AML)

Hannah R. Abrams, Ryan D. Nipp, Lara Traeger, Mitchell W. Lavoie, Matthew J. Reynolds, Thomas W. LeBlanc, Areej El-Jawahri

Blood (2021) 138 (Supplement 1): 109.

https://doi.org/10.1182/blood-2021-146451

Published: 2021

Journal Articles

Symptoms and Impacts Reported By Patients with Acute Myeloid Leukemia (AML) in Remission Post-Stem Cell Transplant

David Cella, Thomas W. LeBlanc, Manasee V. Shah, Anna de la Motte, Farah Toublan, Kimberly Kelly

Blood (2021) 138 (Supplement 1): 278.

https://doi.org/10.1182/blood-2021-145393

Published: 2021

Journal Articles

Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy

David Huggar, Russell L. Knoth, Ronda Copher, Zhun Cao, Craig Lipkin, Ali McBride, Thomas W. LeBlanc

Blood (2021) 138 (Supplement 1): 4039.

https://doi.org/10.1182/blood-2021-148434

Published: 2021

NARROW

An Indirect Comparison of Elranatamab's Progression-Free Survival and Overall Survival from Magnetismm-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study

Multi-Site Randomized Trial of Inpatient Palliative Care for Hospitalized Patients Undergoing Hematopoietic Stem Cell Transplantation

A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH) to Promote Well-Being: Randomized Controlled Feasibility and Preliminary Efficacy Trial

Changing Care Journey for Patients with Multiple Myeloma in the United States

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab and Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma

Multiple Myeloma Treatment-Related Decision-Making and Preferences of Patients and Care Partners in the United States

Measuring Social Toxicity in Acute Myeloid Leukemia

The Role of a Multi-Center Tumor Board Discussion in Managing Acute Leukemia in Under-Resourced Settings

The Mental Health Burden and Quality of Life Impact of Myelodysplastic Syndromes in Patients and Their Caregivers

In Their Own Words: A Qualitative Study of Coping Mechanisms Employed By Patients with Acute Myeloid Leukemia

The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Code Status Transitions in Patients with High-Risk Acute Myeloid Leukemia (AML)

Symptoms and Impacts Reported By Patients with Acute Myeloid Leukemia (AML) in Remission Post-Stem Cell Transplant

Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only